Jefferies Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.85M | Buy |
21,780
+19,346
| +795% | +$1.64M | 0.02% | 362 |
|
|
2022
Q2 | $202K | Sell |
2,434
-6,316
| -72% | -$523K | ﹤0.01% | 825 |
|
|
2022
Q1 | $675K | Buy |
8,750
+960
| +12% | +$74K | ﹤0.01% | 584 |
|
|
2021
Q4 | $688K | Sell |
7,790
-15,557
| -67% | -$1.37M | ﹤0.01% | 638 |
|
|
2021
Q3 | $1.8M | Buy |
23,347
+13,121
| +128% | +$1.01M | 0.01% | 424 |
|
|
2021
Q2 | $853K | Buy |
10,226
+3,796
| +59% | +$317K | 0.01% | 632 |
|
|
2021
Q1 | $486K | Sell |
6,430
-17,663
| -73% | -$1.33M | ﹤0.01% | 720 |
|
|
2020
Q4 | $2.11M | Buy |
24,093
+23,917
| +13,589% | +$2.1M | 0.02% | 364 |
|
|
2020
Q3 | $13K | Sell |
176
-26,146
| -99% | -$1.93M | ﹤0.01% | 842 |
|
|
2020
Q2 | $3.25K | Buy |
26,322
+17,889
| +212% | +$2.21K | 0.04% | 209 |
|
|
2020
Q1 | $713K | Sell |
8,433
-56,947
| -87% | -$4.81M | 0.01% | 542 |
|
|
2019
Q4 | $5.53M | Sell |
65,380
-35,368
| -35% | -$2.99M | 0.04% | 214 |
|
|
2019
Q3 | $6.79M | Buy |
100,748
+82,426
| +450% | +$5.56M | 0.05% | 140 |
|
|
2019
Q2 | $1.57M | Buy |
18,322
+8,855
| +94% | +$758K | 0.01% | 531 |
|
|
2019
Q1 | $841K | Sell |
9,467
-31,405
| -77% | -$2.79M | 0.01% | 776 |
|
|
2018
Q4 | $3.48M | Sell |
40,872
-35,260
| -46% | -$3M | 0.03% | 252 |
|
|
2018
Q3 | $7.38M | Buy |
76,132
+6,159
| +9% | +$597K | 0.05% | 139 |
|
|
2018
Q2 | $6.59M | Buy |
69,973
+64,909
| +1,282% | +$6.11M | 0.04% | 161 |
|
|
2018
Q1 | $411K | Sell |
5,064
-61,947
| -92% | -$5.03M | ﹤0.01% | 982 |
|
|
2017
Q4 | $5.98M | Buy |
67,011
+63,988
| +2,117% | +$5.71M | 0.03% | 203 |
|
|
2017
Q3 | $281K | Sell |
3,023
-16,732
| -85% | -$1.56M | ﹤0.01% | 1208 |
|
|
2017
Q2 | $1.79M | Buy |
+19,755
| New | +$1.79M | 0.01% | 502 |
|
|
2017
Q1 | – | Sell |
-7,192
| Closed | -$596K | – | 1512 |
|
|
2016
Q4 | $596K | Buy |
7,192
+1,271
| +21% | +$105K | ﹤0.01% | 797 |
|
|
2016
Q3 | $548K | Sell |
5,921
-20,073
| -77% | -$1.86M | ﹤0.01% | 795 |
|
|
2016
Q2 | $2.02M | Sell |
25,994
-5,297
| -17% | -$412K | 0.01% | 306 |
|
|
2016
Q1 | $2.58M | Buy |
31,291
+31,144
| +21,186% | +$2.57M | 0.01% | 248 |
|
|
2015
Q4 | $15K | Sell |
147
-19,447
| -99% | -$1.98M | ﹤0.01% | 1247 |
|
|
2015
Q3 | $2.06M | Sell |
19,594
-12,175
| -38% | -$1.28M | 0.01% | 349 |
|
|
2015
Q2 | $4.35M | Buy |
31,769
+13,114
| +70% | +$1.79M | 0.02% | 209 |
|
|
2015
Q1 | $2.32M | Buy |
18,655
+8,673
| +87% | +$1.08M | 0.01% | 309 |
|
|
2014
Q4 | $902K | Sell |
9,982
-7,018
| -41% | -$634K | 0.01% | 475 |
|
|
2014
Q3 | $1.23M | Sell |
17,000
-65,533
| -79% | -$4.73M | 0.01% | 440 |
|
|
2014
Q2 | $5.13M | Sell |
82,533
-8,134
| -9% | -$506K | 0.04% | 117 |
|
|
2014
Q1 | $6.18M | Buy |
90,667
+89,282
| +6,446% | +$6.09M | 0.06% | 75 |
|
|
2013
Q4 | $97K | Sell |
1,385
-17,981
| -93% | -$1.26M | ﹤0.01% | 1087 |
|
|
2013
Q3 | $1.4M | Buy |
19,366
+10,048
| +108% | +$725K | 0.01% | 325 |
|
|
2013
Q2 | $519K | Buy |
+9,318
| New | +$519K | 0.01% | 523 |
|